Clinical follow-up of high mid-trimester maternal serum intact human chorionic gonadotrophin concentrations in singleton pregnancies

Prenatal Diagnosis

Volumn 19, Issue 3, 1999, Pages 219-223

  Blundell, Gillian ^a   Ashby, J Peter ^a   Martin, Cameron ^b   Shearing, Catherine H ^a   Langdale Brown, Barbara ^c   Keeling, Jean ^c   Ellis, Patricia M ^c   Shade, Mary ^c   Chambers, Sarah E ^b   Wenham, Philip R ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

Biochemical antenatal screening; Material serum alpha fetoprotein; Maternal serum intact human chorionic gonadotrophin

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN;

ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; FEMALE; FETUS; FETUS DISEASE; FETUS OUTCOME; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL SERUM; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY;

CHORIONIC GONADOTROPIN; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CHROMOSOMES, HUMAN, PAIR 16; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MATERNAL AGE; MOSAICISM; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY TRIMESTER, SECOND; PREGNANCY, HIGH-RISK; RETROSPECTIVE STUDIES; SCOTLAND; TRISOMY;

EID: 0032971789     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199903)19:3<219::AID-PD512>3.0.CO;2-K     Document Type: Article

References (32)

1. Barkai, G., Goldman, B., Reis, L., Chaki, R., Cuckle, H. (1996). Effect of gravidity on maternal serum markers for Down's syndrome, Prenat. Diagn., 16, 319-322.
2. Beekhuis, J.R., Van Lith, J.M.M., de Wolf, B.T.H.M., Mantingh, A. (1992). Increased maternal serum alpha-fetoprotein and human chorionic gonadotropin in compromised pregnancies other than for neural tube defects or Down syndrome, Prenat. Diagn., 12, 643-647.
3. Benn, P.A. (1997). Down syndrome and open neural tube defect screen-positive pregnancies: premature delivery and premature placental karyotyping, Prenat. Diagn., 17, 282-284.
4. Ben-Neriah, Z., Anteby, E., Zelikoviz, B., Bach, G. (1991). Increased maternal serum human chorionic gonadotropin level associated with Klinefelter's syndrome, Prenat. Diagn., 11, 923-924.
5. Bogart, M.H., Golbus, M.S., Sorg, N.D., Jones, O.W. (1989). Human chorionic gonadotropin levels in pregnancies with aneuploid fetuses, Prenat. Diagn., 9, 379-384.
6. Bogart, M.H., Pandian, M.R., Jones, O.W. (1987). Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities, Prenat. Diagn., 7, 623-630.
7. Bombard, A.T., Nakagawa, S., Runowicz, C.D., Cohen, B.L., Mikhail, M.S., Nitowsky, H.M. (1994). Early detection of abdominal pregnancy by maternal serum AFP+screening, Prenat. Diagn., 14, 1155-1157.
8. Chamberlain, G.V.P. (ed.) (1995a). Obstetrics by Ten Teachers, 16th edn, Sevenoaks: Edward Arnold, 141.
9. Chamberlain, G.V.P. (ed.) (1995b). Obstetrics by Ten Teachers, 16th edn, Sevenoaks: Edward Arnold, 102.
10. Chambers, S.E., Geirsson, R.T., Stewart, R.J., Wannapirak, C., Muir, B.B. (1995). Audit of a screening device for fetal abnormalities using early ultrasound scanning and maternal serum α-fetoprotein estimation combined with selective detailed scanning, Ultrasound Obstet. Gynecol., 5, 168-173.
11. Cusick, W., Bork, M., Fabri, B., Benn, P., Rodis, J.F., Buttino, L. (1995). Trisomy 16 fetus surviving into the second trimester, Prenat. Diagn., 15, 1078-1081.
12. Dar, H., Merksamer, R., Berdichevsky, D., David, M. (1996). Maternal serum marker levels in consecutive pregnancies: a possible genetic predisposition to abnormal levels, Am. J. Med. Genet., 61, 154-157.
13. Eiben, B., Hammans, W., Goebel, R. (1996). Triploidy, imprinting, and hCG levels in maternal serum screening, Prenat. Diagn., 16, 377-378.
14. Fox, H. (1970). Effect of hypoxia on trophoblast in organ culture, Am. J. Obstet. Gynecol., 107, 1058-1064.
15. Gonen, R., Perez, R., David, M., Dar, H., Merksamer, R., Sharf, M. (1992). The association between unexplained second-trimester maternal serum hCG elevation and pregnancy complications, Obstet. Gynecol., 80, 82-85.
16. Gravett, C.P., Buckmaster, J.G., Watson, P.T., Gravett, M.G. (1992). Elevated second trimester maternal serum β-HCG concentrations and subsequent adverse pregnancy outcome, Am. J. Med. Genet., 44, 485-486.
17. Heinonen, S., Ryynänen, M., Kirkinen, P., Saarikoski, S. (1996). Velamentous umbilical cord insertion may be suspected from maternal serum α-fetoprotein and hCG, Br. J. Obstet. Gynaecol., 103, 209-213.
18. Kohn, G., Peisler, E., Malinger, G. (1992). Elevated maternal serum human chorionic gonadotropin associated with a chromosomal deletion, Prenat. Diagn., 12, 853-854.
19. Lechat, M.F. (Editor Responsible) (1991). Surveillance of congenital anomalies 1980-1988, Eurocat Report, 4, 20.
20. Liporrier, N., Herrou, M., Leymarii, P. (1992). Shift of the fetal sex ratio in hCG selected pregnancies at risk for Down syndrome, Prenat. Diagn., 12, 703-704.
21. Mooney, R.A., Arvan, D.A., Saller, D.N., French, C.A., Peterson, C.J. (1995). Decreasing maternal serum hCG levels with increasing gravidity and parity, Obstet. Gynecol., 86, 900-905.
22. Morssink, L.P., Kornman, L.H., Beekhuis, J.R., de Wolf, B.T.H.M., Mantingh, A. (1995). Abnormal levels of maternal serum human chorionic gonadotrophin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery, Prenat. Diagn., 15, 1041-1046.
23. Morssink, L.P., Sikkema-Raddatz, B., Beekhuis, J.R., de Wolf, B.T.H.M., Mantingh, A. (1996a). Placental mosaicism is associated with unexplained second-trimester elevation of MS hCG levels, but not with elevation of MSAFP levels, Prenat. Diagn., 16, 845-851.
24. Morssink, L.P., de Wolf, B.T.H.M., Kornman, L.H., Beekhuis, J.R., van der Hall, T.P.J., Mantingh, A. (1996b). The relation between serum markers in the second trimester and placental pathology: a study on extremely small for gestational age fetuses, Br. J. Obstet. Gynaecol., 103, 779-783.
25. Muller, F., Aegerter, P., Boue, A. (1993). Prospective maternal serum human chorionic gonadotropin screening for the risk of fetal chromosome anomalies and of subsequent fetal and neonatal deaths, Prenat. Diagn., 13, 29-43.
26. Muller, F., Savey, L., Le Fiblec, B., Bussieres, L., Ndayizamba, G., Colau, J.C., Giraudet, P. (1996). Maternal serum human chorionic gonadotrophin level at fifteen weeks is a predictor for preeclampsia, Am. J. Obstet. Gynecol., 175, 37-40.
27. Oyer, C.E., Canick, J.A. (1992). Maternal serum hCG levels in triploidy: variability and need to consider molar tissue, Prenat. Diagn., 12, 627-628.
28. 3) in the mid-trimester of pregnancy, Am. J. Hum. Genet., 51, A1039.
29. Scottish Stillbirth and Infant Death Report (1995). 23.
30. Tanaka, M., Natori, M., Kohno, H., Ishimoto, H., Kobayashi, T., Nozawa, S. (1993). Fetal growth in patients with elevated maternal serum hCG levels, Obstet. Gynecol., 81, 341-343.
31. Valerio, D. (1994). Maternal serum screening and triploidy, Prenat. Diagn., 14, 413-418.
32. Zimmerman, R., Lauper, U., Streicher, A., Huch, R., Huch, A. (1995). Elevated alpha-fetoprotein and human chorionic gonadotrophin as a marker for placental trisomy 16 in the second trimester?, Prenat. Diagn., 15, 1121-1124.